Home > Healthcare > Medical Devices > Implantable Devices > Elbow Replacement Market

Elbow Replacement Market - By Product (Partial, Total, Revision), Material (Stainless Steel, Cobalt-Chromium Alloys, Titanium Alloys), Indication (Osteoarthritis, Rheumatoid Arthritis, Fracture), End-use (Hospital, ASC) – Global Forecast, 2024 – 2032

  • Report ID: GMI8267
  • Published Date: Feb 2024
  • Report Format: PDF

Elbow Replacement Market Size

Elbow Replacement Market size was valued at around USD 244.4 million in 2023 and is estimated to grow at 7.4% CAGR from 2024 to 2032. This robust market growth can be attributed to various factors, including ongoing advancements in technology, an increasing incidence of elbow injuries, a rising demand for minimally invasive procedures, the continual growth of healthcare expenditure, and an escalating awareness among patients and healthcare providers, among other contributing factors.

Elbow Replacement Market

Moreover, the aging global population is an important factor in the growth of the elbow replacement industry. As people age, they become more vulnerable to degenerative joint diseases including osteoarthritis and rheumatoid arthritis. These diseases can cause severe discomfort, stiffness, and loss of function in the elbow joint, demanding surgical intervention, such as elbow replacement.

For instance, according to a recent United Nations (UN) research, the number of people aged 65 and over globally is predicted to treble over the next three decades. The senior population is expected to reach 1.6 billion by 2050, accounting for more than 16% of the worldwide population.

Furthermore, advances in implant design, materials, and surgical methods have greatly improved the safety, effectiveness, and life span of elbow replacement surgeries. Modern elbow implants are intended to precisely resemble the anatomy and biomechanics of the native elbow joint, leading in improved functional results and patient satisfaction, thereby contributing to the market growth.

Elbow replacement is a surgical procedure performed to replace a damaged or diseased elbow joint with an artificial implant. It is typically indicated for individuals with severe elbow arthritis, trauma-related injuries, or other degenerative conditions that cause significant pain, stiffness, and loss of function in the elbow joint.

Elbow Replacement Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Factors such as continuous technological advancements in implant design, rising need for robotic-assisted surgery, and a surging demand for minimally invasive surgical techniques, among other factors are propelling the industry growth.

  • Further, there is a rising interest in biologic solutions for elbow injuries and degenerative conditions, including biological augmentation and tissue engineering approaches. Biological treatments aim to promote tissue healing, regenerate cartilage, and enhance joint stability, offering potential alternatives or adjuncts to traditional elbow replacement surgery.
  • Moreover, robotic-assisted surgery is gaining acceptance in the field of orthopedics, including elbow replacement procedures. Surgical robots offer enhanced precision, intraoperative visualization, and real-time feedback for surgeons, leading to more accurate implant placement and improved surgical outcomes.

Elbow Replacement Market Analysis

Elbow Replacement Market, By Product, 2021 – 2032 (USD Million)

The market by product is categorized into total elbow replacement, partial elbow replacement, and revision elbow replacement. The total elbow replacement segment garnered USD 145.2 million revenue in 2023.

  • The prevalence of elbow arthritis, including rheumatoid arthritis and post-traumatic arthritis, is growing worldwide. Arthritis damages the elbow joint over time, causing discomfort, swelling, and a reduced range of motion. Total elbow replacement is an effective treatment option for individuals with chronic arthritis that have exhausted conservative treatments. As per the National Health Interview Survey (NHIS), from 2019 to 2021, in U.S., the overall number of people with arthritis was 24.2% among women and 17.9% among men, respectively.
  • Furthermore, the demand for minimally invasive surgical instrument in total elbow replacement has increased in recent years. Minimally invasive approaches involve smaller incisions, reduced tissue trauma, and faster recovery times compared to traditional open surgery. Patients benefit from less post-operative pain, shorter hospital stays, and quicker return to daily activities. This is anticipated to boost the segmental growth in the market positively.
Elbow Replacement Market, By Material Type (2023)

Based on material type, the elbow replacement market is segmented into cobalt-chromium alloys, titanium alloys, stainless steel, and other materials. The cobalt-chromium alloys segment accounted for 51.5% business share in 2023 and is anticipated to witness significant growth during the forecast period.

  • Cobalt-chromium alloys exhibit excellent biocompatibility, making them suitable for use in orthopedic implants. These alloys have low reactivity and corrosion resistance properties, which minimize the risk of adverse tissue reactions and implant-related complications following elbow replacement surgery.
  • Moreover, it possess high strength, hardness, and wear resistance, making them well-suited for load-bearing applications in the elbow joint. These mechanical properties enable cobalt-chromium implants to withstand the forces and stresses encountered during daily activities, thereby ensuring long-term durability and stability of the implant.

Based on indication, the elbow replacement market is segmented into osteoarthritis, post-traumatic arthritis, rheumatoid arthritis, fracture, and other indications. The osteoarthritis segment dominated the market and accounted for 46.2% business share in 2023.

  • Continuous advancements in surgical techniques, implant materials, and rehabilitation protocols have made elbow replacement surgery a viable option for patients with severe osteoarthritis. These advancements have widened the eligible patient population and contributed to the growth of osteoarthritis as a leading indication for elbow replacements.
  • Additionally, favorable reimbursement policies from insurance providers and government healthcare programs for joint replacement surgeries, particularly for osteoarthritis, incentivize both patients and healthcare providers to opt for surgical interventions, further enhancing its market share.

The elbow replacement market by end-use is categorized into hospitals, orthopedic clinics, and ambulatory surgical centers. The hospitals segment accounted for around USD 132.7 million revenue size in 2023.

  • Growing awareness among patients about the benefits of joint replacement surgeries, including elbow replacement, coupled with increased acceptance of surgical interventions, has led to a higher number of procedures being performed in hospital settings.
  • Advancements in implant materials, surgical techniques, and prosthetic design have made elbow replacement surgeries more effective, safer, and with better outcomes, encouraging more hospitals to offer these procedures. These factors collectively contribute to the growth of the market specifically within hospital settings.
North America Elbow Replacement Market, 2020 – 2032 (USD Million)

North America elbow replacement market accounted for USD 98.1 million revenue in 2023 and is predicted to witness substantial market growth.

  • In North America, the market is thriving due to several key factors. Firstly, the region hosts major orthopedic implant manufacturers and specialized healthcare providers, fostering a competitive landscape that drives innovation and market expansion.
  • The regions significant aging population, prone to degenerative joint diseases such as osteoarthritis, fuels demand for joint replacement surgeries, including elbow replacements. This demographic trend is a primary driver of market growth as the need for surgical interventions escalates with age.
  • Moreover, the presence of comprehensive health insurance coverage and favorable reimbursement policies incentivizes patients to opt for joint replacement procedures. This financial support encourages higher procedure rates, consequently boosting the market for elbow replacements.
  • Advancements in implant materials, surgical techniques, and prosthetic designs have significantly enhanced the outcomes of elbow replacement surgeries. As a result, these technological innovations attract more patients seeking effective treatment options and contribute to the overall expansion of the market.

Elbow Replacement Market Share

The elbow replacement industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Arthrex, Inc., Johnson & Johnson (DePuy Synthes), Orthofix US LLC, Stryker Corporation, Zimmer Biomet Holdings, Inc., among others have a notable presence in the market.

Elbow Replacement Market Companies

Some of the eminent market participants operating in the elbow replacement industry include:

  • Acumed LLC.
  • Arthrex, Inc.
  • DJO, LLC
  • Johnson & Johnson (DePuy Synthes)
  • Limacorporate S.p.A.
  • Ottobock
  • Stryker Corporation
  • Wright Medical Group N.V.
  • Zimmer Biomet Holdings, Inc.

Elbow Replacement Industry News:

  • In February 2020, In2Bones Global, Inc. has launched the Avenger Radial Head Prosthesis System in the U.S. for primary and revision radial head joint replacements. The novel prosthesis restores elbow joint function and provides various advantages to surgeons and patients over conventional prosthetic devices.
  • In October 2020, DePuy Synthes announced the launch of their Radial Head Replacement System in the U.S. The Radial Head Replacement System is designed to treat individuals who have suffered unstable radial head fractures that cannot be healed. The Radial Head Replacement System is also effective for the elective treatment of elbow arthritis.

Elbow replacement market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

  • Total elbow replacement
  • Partial elbow replacement
  • Revision elbow replacement

Market, By Material Type

  • Cobalt-chromium alloys
  • Titanium alloys
  • Stainless steel
  • Other materials

Market, By Indication

  • Osteoarthritis
  • Post-traumatic arthritis
  • Rheumatoid arthritis
  • Fracture
  • Other indications

Market, By End-use

  • Hospitals
  • Orthopedic clinics
  • Ambulatory surgical centers

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global elbow replacement industry was valued at around USD 244.4 million in 2023 and is estimated to reach over USD 474 million by 2032, attributed to the ongoing advancements in technology, an increasing incidence of elbow injuries, and a rising demand for minimally invasive procedures.

The total elbow replacement segment garnered USD 145.2 million in 2023 and will grow through 2032 as it is an effective treatment option for individuals with chronic arthritis that have exhausted conservative treatments.

North America elbow replacement industry accounted for over USD 98.1 million in 2023 and is predicted to witness substantial growth through 2032 as the region hosts major orthopedic implant manufacturers and specialized healthcare providers.

Acumed LLC., Arthrex, Inc., DJO, LLC, Johnson & Johnson (DePuy Synthes), Limacorporate S.p.A., ORTHOFIX MEDICAL INC, Ottobock, Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc.

Elbow Replacement Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 208
  • Countries covered: 22
  • Pages: 110
 Download Free Sample